Cargando…
Comparison of adjuvant ED and EC-D regimens in operable breast invasive ductal carcinoma
In China, the adjuvant epirubicin and docetaxel (ED) regimen is widely used as a substitute for the epirubicin and cyclophosphamide followed by docetaxel (EC-D) regimen in patients with operable breast cancer. However, their equivalence has not yet been demonstrated. This retrospective study compare...
Autores principales: | Jiang, Liyu, Jing, Chuyu, Kong, Xiaoli, Li, Xiaoyan, Ma, Tingting, Huo, Qiang, Chen, Junfei, Wang, Xiaoting, Yang, Qifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950445/ https://www.ncbi.nlm.nih.gov/pubmed/27446451 http://dx.doi.org/10.3892/ol.2016.4754 |
Ejemplares similares
-
Adjuvant, neoadjuvant, and experimental regimens in overcoming pancreatic ductal adenocarcinoma
por: Wysocka, Olga, et al.
Publicado: (2016) -
Clinicopathological features of granulomatous lobular mastitis and mammary duct ectasia
por: Jiang, Liyu, et al.
Publicado: (2020) -
Precise intraoperative sentinel lymph node biopsies guided by lymphatic drainage in breast cancer
por: Li, Xiaoyan, et al.
Publicado: (2017) -
Acute Treatment Regimens for Migraine in the ED
por: Millichap, J. Gordon
Publicado: (2015) -
Identification and preservation of stained non-sentinel lymph nodes in breast cancer
por: Li, Xiaoyan, et al.
Publicado: (2020)